1Ehud Zamir. Central serous retinopathy associated with adrenocorticotrophic hormone therapy[J] 1997,Graefe’s Archive for Clinical and Experimental Ophthalmology(6):339～344
4Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serousChorioretinopathy: a case-control study. Ophthalmology, 2004,111 : 244-249.
5Tewari HK, Gadia R, Kumar D, et al. Sympatheticparasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study. Invest Ophthalmol Vis Sci, 2006, 47:3474-3478.
7Yoshioca H, Katswhe Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica, 1982, 195:168-178.
8Gragoudas HES,Duker JS.Central serous chorioretinopathy associated with inhaled or intranasal corticosteroides.Ophthalmology,1997,104:1653-1660.
9Zamir E. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis [J]. Graefe's Arch Clin Exp Ophthalmol, 1997,235: 339 ～ 344.
